Dopamine D4and D2LReceptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent ontrans-Activation of the Platelet-Derived Growth Factor Receptor
Authors:
- Natalie LavineNLNatalie Lavine
- Hubert H. M. Van TolHTHubert H. M. Van Tol
- 1 July 2001
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 60 (1) , 92-103
Abstract
The ability of dopamine D4 and D2 receptors to activate extracellular signal-regulated kinases (ERKs) 1 and 2 was compared using Chinese hamster ovary (CHO-K1) cells transfected with D4.2, D4.4, D4.7, and D2L receptors. Dopamine stimulation of D4 or D2L receptors produced a transient, dose-dependent increase in ERK1/2 activity. Receptor-specific activation of the ERK mitogen-activated protein kinase (MAPK) pathway was confirmed using the D2-like receptor-selective agonist quinpirole, whereas the specific antagonist haloperidol blocked activation. MAPK stimulation was dependent on a pertussis-toxin-sensitive G protein (Gi/o). trans-Activation of the platelet-derived growth factor (PDGF) receptor was an essential step in D4 and D2L receptor-induced MAPK activation. PDGF receptor-selective tyrosine kinase inhibitors tyrphostin A9 and AG1295 abolished or significantly inhibited ERK1/2 activation by D4 and D2L receptors. Dopamine stimulation of the D4 receptor also produced a rapid increase in tyrosine phosphorylation of the PDGF receptor-β. The Src-family tyrosine kinase inhibitor PP2 blocked MAPK activation by dopamine; however, this drug was also found to inhibit PDGF-BB-stimulated ERK activity and autophosphorylation of the PDGF receptor-β. Downstream signaling pathways support the involvement of a receptor tyrosine kinase. The phosphoinositide 3-kinase inhibitors wortmannin and LY294002, protein kinase C inhibitors GF109203X and Calphostin C, dominant-negative RasN17, and the MEK inhibitor PD98059 significantly attenuated or abolished activation of MAPK by dopamine D4 and D2L receptors. Our results indicate that D4 and D2L receptors activate the ERK kinase cascade by first mobilizing signaling by the PDGF receptor, followed by the subsequent activation of ERK1/2 by pathways associated with this receptor tyrosine kinase.Keywords
This publication has 39 references indexed in Scilit:
- PLC-γ activation is required for PDGF-βR-mediated mitogenesis and monocytic differentiation of myeloid progenitor cellsOncogene, 1997
- A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activationNature, 1996
- Binding to the Platelet-derived Growth Factor Receptor Transiently Activates the p85α-p110α Phosphoinositide 3-Kinase Complex in VivoJournal of Biological Chemistry, 1996
- Phosphatidylinositol 3-Kinase Is an Early Intermediate in the Gβγ-mediated Mitogen-activated Protein Kinase Signaling PathwayJournal of Biological Chemistry, 1996
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996
- Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor VariantsJournal of Neurochemistry, 1995
- Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteinsJournal of Biological Chemistry, 1995
- Bradykinin Induces Translocation of the Protein Kinase C Isoforms α, ɛ, and ζEuropean Journal of Biochemistry, 1994
- Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell lineEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Dopamine Inhibits TRH-Induced MAP Kinase Activation in Dispersed Rat Anterior Pituitary CellsBiochemical and Biophysical Research Communications, 1994